MAPT and neurodegenerative disease: Based on accumulating evidence, Aβ and tau are involved in the pathophysiology of several neurodegenerative diseases, and differences in their levels have been identified in different diseases (Riemenschneider et al., 2003; Ritchie et al., 2013; Jeppsson et al., 2013; Baiardi et al., 2018).